Genetic Technologies Limi...

NASDAQ: GENE · Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM

Genetic Cash Flow Statement

Financials in AUD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-12.02M -11.75M -7.13M -7.08M
Depreciation & Amortization
534.89K 676.58K 578.67K 478.22K
Stock-Based Compensation
n/a 253.45K 437.51K 714.58K
Other Working Capital
156.03K 432.36K -2.18M 14.99K
Other Non-Cash Items
1.53M 1.35M 892.87K 303.47K
Deferred Income Tax
n/a -581.92K 1.8M -444.07K
Change in Working Capital
275.46K 328.47K -2.24M -270.51K
Operating Cash Flow
-9.68M -9.72M -5.66M -6.3M
Capital Expenditures
-32.97K -17.55K -96.79K -642K
Cash Acquisitions
n/a -486.19K -3.48M n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
147.87K 191.8K 82.79K n/a
Investing Cash Flow
114.9K -311.94K -3.49M -642K
Debt Repayment
252.09K -336.4K -268.59K -236.89K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-6.85K -916.06K n/a -1.97M
Financial Cash Flow
2.82M 5.92M -279.06K 13.94M
Net Cash Flow
-6.83M -3.88M 21.37M 6.69M
Free Cash Flow
-9.71M -9.74M -5.76M -6.94M